Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 1
Search results for: lumiracoxib
1 A New Gateway for Rheumatoid Arthritis: COXIBs with a Safety Cardiovascular Profile
Authors: Malvina Hoxha, Valerie Capra, Carola Buccellati, Angelo Sala, Clara Cena, Roberta Fruttero, Massimo Bertinaria, G. Enrico Rovati
Abstract:
Today COXIBs are used in the treatment of arthritis and many other painful conditions in selected patients with high gastrointestinal risk and low CV risk. Previously we found a new mechanism of action of a traditional NSAID (diclofenac) and a COXIB (lumiracoxib) that possess weak competitive antagonism at the TP receptor. We hypothesize that modifying the structure of a known specific inhibitor of cyclooxygenase-2 (COXIB), so that it becomes also a more potent thromboxane antagonist will preserve the anti-inflammatory and gastrointestinal safety typical of COXIBs and prevent the cardiovascular risk associated with long term therapy.Keywords: cyclooxygenase, inflammation, lumiracoxib, thromboxane A2
Procedia PDF Downloads 303